Jennerex Biotherapeutics has presented positive results from a Phase I and II trial of a genetically-engineered vaccinia virus strain that is suited to treat cancers.

• 提示：欢迎您来到肝宝宝乙肝论坛，您目前的身份是游客，所以只能阅读部份内容。